Article Information
History
- July 19, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mohammadreza Naderian, MD, MPH1,
- Marwan E. Hamed, MD1,
- Ali A. Vaseem1,
- Kristjan Norland, MS1,
- Ozan Dikilitas, MD2,
- Azin Teymourzadeh, MD, MPH1,
- Kent R. Bailey, PhD3 and
- Iftikhar J. Kullo, MD*,1,4
- 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
- 2Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
- 3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota
- 4Gonda Vascular Center, Mayo Clinic, Rochester, MN, USA
- ↵*Corresponding Author
: Iftikhar J. Kullo, MD, Department of Cardiovascular Medicine and the Gonda Vascular Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Phone: 507-284-2511, Email: kullo.iftikhar{at}mayo.edu, Twitter: @iftikhar_kullo
Posted July 19, 2024.
Effect of disclosing a polygenic risk score for coronary heart disease on adverse cardiovascular events: 10-year follow-up of the MI-GENES randomized clinical trial
